Medical/Pharmaceuticals

The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director

HONG KONG, Aug. 11, 2021 /PRNewswire/ -- Insilico Medicine, a global leader in end-to-end AI-powered drug discovery, today announced the appointment ofSteven Galson, MD, MPH as the independent member of the board of directors. "Successful drug development depends on speed and increasing the rates...

2021-08-11 20:31 4026

Sihuan Pharmaceutical (0460.HK): Say "No" to Smuggled Products - Advocate 'Positive Energy' of China's Medical Aesthetics Industry

HONG KONG, Aug. 11, 2021 /PRNewswire/ -- On June 10, 2021, the National Health Commission, leading eight ministries and commissions,  issued the"Notice on Distributing the Special Rectification Work Plan for Combating Illegal Medical Aesthetic Services." On August 9, 2021, 'The People's Daily' pu...

2021-08-11 17:59 5088

Invitation to the presentation of Elekta's first quarter 2021/22

STOCKHOLM, Aug. 11, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the first quarter 2021/22 at10:00 a.m. CEST onAugust 25. The interim report for the first quarter will be published at 7:30 a.m. CEST on the same day. The company's development will be...

2021-08-11 14:16 2658

PT Anugerah Pharmindo Lestari (APL) Won 'Community Initiative' Award and 'Outstanding Leader in Asia' Title for Its President Director at the Asia Corporate Excellence & Sustainability Awards 2021

JAKARTA, Indonesia, Aug. 11, 2021 /PRNewswire/ -- PT Anugerah Pharmindo Lestari (APL), a member of Zuellig Pharma, a leading healthcare services company in Indonesia, has been awarded with the 'Community Initiative' and 'Outstanding Leader inAsia' for APL's President Director, Christophe Piganiol,...

2021-08-11 09:00 2795

Zuellig Pharma Singapore Named 'Industry Champions of the Year' at the Asia Corporate Excellence & Sustainability Awards 2021

SINGAPORE, Aug. 11, 2021 /PRNewswire/ -- Zuellig Pharma Singapore, a leading healthcare services provider inSingapore, has been presented with the 'Industry Champions of the Year' title at the recent Asia Corporate Excellence and Sustainability (ACES) Awards. Held annually, the ACES Awards is a p...

2021-08-11 09:00 3742

Ascensia Presents First Ever Data At Australasian Diabetes Conference 2021 Exploring The Profiles Of Australian Contour®Diabetes App Users

SYDNEY, Aug. 11, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes company has today disclosed data at the virtual Australasian Diabetes Conference (ADC) 2021, which takes placeAugust 11-13. The two posters presented for the first time data that analysed CONTOUR®DIABETES App (CDA) us...

2021-08-11 07:00 2538

DERMALOG is one of Germany's most innovative SMEs

Again, DERMALOG has been ranked as one of the most innovative companies in Germany this year. The biometrics company thus ranks in the top group as number 14 of the approximately 4,000 German companies evaluated HAMBURG, Germany, Aug. 10, 2021 /PRNewswire/ -- The German WirtschaftsWoche magazine...

2021-08-10 22:17 6837

Novaliq Completes Enrollment of Second Phase 3 Study for CyclASol® for the Treatment of Dry Eye Disease

HEIDELBERG, Germany and CAMBRIDGE, MA, Aug. 10, 2021 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced the second of two Phase 3 (ESSENCE-2) studies, evaluating the inves...

2021-08-10 20:00 4372

Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with Its Systems Integration Solution

LONDON, Aug 10, 2021 /PRNewswire/ -- Based on its recent analysis of the global market for operating room (OR) systems integration,Frost & Sullivan recognizes FUJIFILM Medical SystemsUSA, Inc. with the 2021 Global New Product Innovation Award. Its systems integration solution comprising Intellige...

2021-08-10 20:00 2826

Dymicron® Names Gunther Peeters as Senior Vice President of Commercial Operations

Gunther Peeters to spearhead international commercialization of Dymicron's next-generation cervical disc replacement system OREM, Utah, Aug. 10, 2021 /PRNewswire/ -- Dymicron today announced it has appointedGunther Peeters as Senior Vice President of Commercial Operations. With more than 15 year...

2021-08-10 14:17 1546

Orizuru Therapeutics Launches Operations as Research and Development-driven Company for Products Including induced Pluripotent Stem Cell (iPSC) Regenerative Medicine

* Contributing to society and patients through the utilization of iPSC technology developed inJapan * New company to advance two successful outcomes from T-CiRA collaboration for severe heart failure and type I diabetes to clinical application of iPSC-based medicine KYOTO, Japan, Aug. 10, 2...

2021-08-10 14:00 2987

Australia's Cancer Organisations Unite to Urgently Tackle 'Symptom Hesitancy' and Testing 'Rollercoaster' During Pandemic

'New Normal, Same Cancer: Conversations' warns people to get unusual and persistent symptoms checked by their doctor now, to increase detection and improve survival chances, following a slump in cancer testing and screening during the COVID-19 pandemic. * Growing concern among Australian cance...

2021-08-10 04:00 2919

Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas

HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic partnership will involve Insilico Medicine's AI-augmented platforms and close cooperation between Arvinas' and Insilico Medicine's scientists on novel PR...

2021-08-09 21:47 4385

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from New Zealand

BEIJING, Aug. 9, 2021 /PRNewswire/ -- YishengBio Co., Ltd ("YishengBio") today announced that it received IND clearance for PIKA recombinant COVID-19 vaccine (CHO cell, S Protein) to conduct Phase I clinical trial from New Zealand Medicines and Medical Devices Safety Authority ("MEDSAFE"), which ...

2021-08-09 21:00 3861

Life Sciences' Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

The US digital therapeutics market is estimated to witness more than three-and-a-half-fold growth reaching$4.54 billion by 2025, at a CAGR of 29.8%, finds Frost & Sullivan SANTA CLARA, Calif., Aug. 9, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that digital therapeutics (DTx) i...

2021-08-09 18:02 2922

Thailand's Jan-June Investment Applications Reach USD12 billion, as FDI Quadruple, E&E and Medical Sectors Continue to Expand, BOI says

BANGKOK, Aug. 9, 2021 /PRNewswire/ -- In the first six months of 2021, Thailand's investment applications increased 14% from the year earlier period in terms of the number of projects, and 158% in combined value, led by increasing foreign direct investment (FDI) applications, sustained growth in ...

2021-08-09 15:35 2740

Antengene and MindRank AI Enter into Collaboration to Advance the Development of Difficult-to-Drug Molecular Targets

SHANGHAI and HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...

2021-08-09 08:30 4266

China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne

HANGZHOU and SHAOXING, China, Aug. 9, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Phase II clinical trial application of ASC40 for the treatment of patients with moderate to severe acne. T...

2021-08-09 08:30 4775

Innovent Announces the Establishment of the Scientific Advisory Board

SAN FRANCISCO and SUZHOU, China, Aug. 9, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-08-09 08:04 6108

Endurance Longevity Announces Positive Profit Alert for Interim Results 2021 and Other Exciting Business Updates

HONG KONG, Aug. 6, 2021 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to announce a positive profit alert for the interim results 2021 for the six month period ended30 June 2021. The ...

2021-08-06 20:02 47995